Follow-up study after first-time bypass surgery
Part of Heart & circulation clinical trials.
This study follows patients who had a first-time heart bypass operation (CABG) to see how a blood-thinning medicine called ticagrelor affects their recovery and long-term health. It may help doctors understand the best way to prevent complications after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled for your first heart bypass surgery (using at least one vein from your leg).
- You do not need any other heart surgery at the same time (like valve or rhythm surgery).
- You have not had a recent heart attack requiring emergency surgery.
- You can take aspirin and ticagrelor after surgery, and you are not currently taking other blood thinners or antiplatelet drugs that you cannot stop.
- You do not have severe kidney or liver disease, active bleeding risk, or a recent stent placement in your heart or brain arteries.
- If you are a woman of childbearing age, you are not pregnant, breastfeeding, or recently gave birth, and you agree to use reliable contraception.
- Your surgeon has performed at least 50 bypass surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different lengths of time for taking a blood thinner after heart bypass surgery to see which is safer and works better. It may help reduce the risk of blood clots or bleeding after surgery.
This Phase 3 trial compares two strategies to prevent blood clots after heart bypass surgery: aspirin alone versus aspirin plus ticagrelor. It aims to see which approach works better and is safer for people whose bypass does not fully restore blood flow.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
This trial tests whether a blood-thinner drug called cangrelor helps patients who are having a special type of bypass surgery that uses a small incision instead of opening the whole chest. The surgery connects a healthy artery from your chest wall directly to a blocked heart vessel to restore blood flow.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.